Target intelligence / Profile preview

Zinc-dependent enzymes and zinc-finger domains (Zn-proteins)

Target
Zn-proteins
Molecular classification
Enzyme, Transcription factor, DNA-binding protein, Metalloenzyme
01

Overview

Zinc-dependent proteins, encompassing both zinc-dependent enzymes and zinc-finger domains, represent a vast and diverse class of molecules essential for numerous physiological processes [6]. Zinc-dependent enzymes, such as matrix metalloproteinases (MMPs), carbonic anhydrases (CAs), and histone deacetylases (HDACs), utilize the Lewis acid properties of the zinc cation to facilitate catalytic reactions involved in metabolism, tissue remodeling, and epigenetic regulation [4, 5, 10]. Zinc-finger domains are among the most common protein motifs in the human genome, primarily functioning as DNA-binding modules in transcription factors to regulate gene expression and maintain genomic integrity [1, 2, 8]. Because of their critical roles in disease pathogenesis, these proteins are major therapeutic targets for conditions including hypertension, glaucoma, cancer, and viral infections [2, 3, 10]. Drugs targeting these proteins often employ zinc-chelating groups, such as hydroxamic acids, or act as molecular glues to induce the degradation of specific zinc-finger transcription factors [10, 11]. However, the ubiquity of zinc-binding motifs across the proteome poses significant challenges for achieving drug selectivity and avoiding systemic toxicity or off-target effects [2, 10].

Other names
Zinc-binding proteinsZinc-metalloproteinsZinc-finger proteinsZinc-dependent metalloenzymes
02

Mechanism of action

Inhibition of catalytic activity via zinc chelation or active site blocking; targeted protein degradation via molecular glues; disruption of DNA-binding and protein-protein interactions.

03

Biological functions

CatalysisGene expression regulationDNA repairSignal transductionProtein-protein interactionPeptide homeostasis
04

Disease associations

CancerCardiovascular diseaseInflammationNeurodegenerative diseaseInfectionGlaucoma
05

Safety considerations

Off-target effects due to motif ubiquityMetal ion homeostasis disruptionToxicity from non-specific chelationHeavy metal displacement toxicityImmunogenicity of engineered domains
06

Interacting drugs

Captopril

7 more in the full profile.

07

Biomarkers

Serum zinc levelsEnzyme activity levelsHistone acetylation levelsZinc-finger protein expression levels

Beyond the preview

Go deeper on Zinc-dependent enzymes and zinc-finger domains (Zn-proteins).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc-dependent enzymes and zinc-finger domains (Zn-proteins).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call